<DOC>
	<DOCNO>NCT01609647</DOCNO>
	<brief_summary>High platelet reactivity unit ( PRU ) load dose clopidogrel patient undergo percutaneous coronary intervention ( PCI ) relate high risk short long term recurrent ischemic event include stent thrombosis . The investigator hypothesize additional loading prasugrel patient high PRU clopidogrel load would superior additional loading clopidogrel reduce platelet reactivity thereby result low risk short term recurrent ischemic event .</brief_summary>
	<brief_title>Reloading Prasugrel Clopidogrel High Platelet Reactivity Before Percutaneous Coronary Intervention</brief_title>
	<detailed_description>Dual antiplatelet therapy acetylsalicyclic acid ( ASA ) additional clopidogrel standard regimen prevention recurrent ischemic event patient undergo PCI . But decreased effect clopidogrel group patient report know associated high risk recurrent ischemic event . Decreased effect clopidogrel mainly result decreased function metabolite prodrug , clopidogrel active form drug . Prasugrel , new thienopyridine recently develop show advantage clopidogrel . Prasugrel known shorter onset time achieve steady state level clopidogrel constant pharmacologic effect regardless patient diversity . High PRU load dose clopidogrel patient undergoing PCI know related increase risk short long term recurrent ischemic event include stent thrombosis . Prasugrel report effective reduce platelet reactivity patient show resistance clopidogrel high PRU . The investigator hypothesize additional loading prasugrel patient high PRU clopidogrel load would superior additional loading clopidogrel reduce platelet reactivity thereby result reduce risk short term recurrent ischemic event . The investigator plan include 70 acute coronary syndrome patient plan undergo PCI show high platelet reactivity . Most patient ACS administer load dose ASA clopidogrel soon assume ACS . The investigator plan perform platelet reactivity test VeryfyNow ( VN ) PCI enroll patient high PRU define 235 . They randomly administer additional 300mg clopidogrel 20mg prasugrel .</detailed_description>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Prasugrel Hydrochloride</mesh_term>
	<criteria>Acute coronary syndrome Patients plan undergo percutaneous transluminal coronary angioplasty Patients agree experimental plan permit IRB Low body weight ( &lt; 50kg ) Urgent PCI ACS Use glycoprotein IIb/IIIa inhibitor recent 24hrs plan History transient ischemic attack History upper gastrointestinal bleeding recent 6 month Renal dysfunction define serum creatinine &gt; 2.5 mg/dl Severe hepatic dysfunction define serum transaminase &gt; 3 time normal limit Bleeding tendency Anticoagulation treatment include warfarin Thrombocytopenia define platelet &lt; 100,000/ml Anemia define hemoglobin &lt; 10 g/dl Contraindication study drug</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>High plate reactivity unit load dose clopidogrel</keyword>
</DOC>